Behaviour of fibrinolysis in the nephrotic syndrome
- PMID: 3133746
Behaviour of fibrinolysis in the nephrotic syndrome
Abstract
When compared to 39 normal-weight normolipidemic control subjects, the dilute blood clot lysis time was found to be slightly (p less than 0.05) accelerated in the 49 investigated nephrotic patients, although their plasma fibrinogen, factor XIII as well as the inhibitors of fibrinolysis, are markedly increased. These findings indicate that the fibrinolytic system as a whole is not markedly depressed in the nephrotic syndrome. Although the fibrinolytic activity of euglobulins tested on agarose-fibrin plates was not significantly increased in nephrotic patients, one cannot definitely preclude an enhanced secretion of plasminogen activators in this pathological condition. A different quality of the inhibitors which may be less active in retarding dilute blood clot lysis time could also be considered.
Similar articles
-
Tissue-type plasminogen activator (t-PA) and dilute blood clot lysis time in nephrotic patients.Thromb Haemost. 1989 Apr 25;61(2):270-4. Thromb Haemost. 1989. PMID: 2501897
-
Plasma fibronectin and factor XIII in nephrotic syndrome.Med Interne. 1987 Apr-Jun;25(2):105-11. Med Interne. 1987. PMID: 3112925
-
Alpha 2-antiplasmin, plasminogen activator inhibitor (PAI) and dilute blood clot lysis time in selected disease states.Thromb Haemost. 1991 Nov 1;66(5):586-91. Thromb Haemost. 1991. PMID: 1725069
-
Hemostatic variables in nephrotic patients.Rom J Intern Med. 1991 Jan-Jun;29(1-2):55-64. Rom J Intern Med. 1991. PMID: 1844391 Review.
-
Blood clotting and fibrinolysis in pregnancy.Postgrad Med J. 1979 May;55(643):362-6. doi: 10.1136/pgmj.55.643.362. Postgrad Med J. 1979. PMID: 382169 Free PMC article. Review.